| Main | News | Articles | Papers |

COVID-19 Scientific Papers
updated April 13, 2020 07:00 EDT

Caveat 1: There are thousands of papers being published and this is not in any way a representative sample.
Caveat 2: Research is happening at a very rapid pace, so keep in mind that something published just a few months or weeks ago may have already been superseded.

Earlier

  • 03/25/2008 Modeling targeted layered containment of an influenza pandemic in the United States | PNAS
  • 09/02/2014 Quantification of Shared Air: A Social and Environmental Determinant of Airborne Disease Transmission
  • 03/02/2016 Pre-fusion structure of a human coronavirus spike protein | Nature
  • 07/11/2017 Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen | PNAS

    January 2020

  • 01/27 Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, China - Wang - 2020 - Journal of Medical Virology - Wiley Online Library
  • 01/30 Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany | NEJM

    February 2020

  • 02/09 Far-UVC light: A new tool to control the spread of airborne-mediated microbial diseases | Scientific Reports

    March 2020

  • 03/03 Fractal kinetics of COVID-19 pandemic | medRxiv
  • 03/09 Temperature and Latitude Analysis to Predict Potential Spread and Seasonality for COVID-19 :: SSRN
  • 03/16 Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand - Imperial College London [PDF]
  • 03/17 The proximal origin of SARS-CoV-2 | Nature Medicine
  • 03/17 Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 | NEJM
  • 03/27 Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma | JAMA | JAMA Network

    April 2020

  • 04/03 Respiratory virus shedding in exhaled breath and efficacy of face masks | Nature Medicine
  • 04/06 Quantifying the effect of quarantine control in Covid-19 infectious spread using machine learning | medRxiv
  • 04/07 Indoor transmission of SARS-CoV-2 | medRxiv
  • 04/07 Early Release - High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2 - Volume 26, Number 7—July 2020 - Emerging Infectious Diseases journal - CDC
  • 04/10 Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China | Global Health | JAMA | JAMA Network
  • 04/10 Early Release - Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China, 2020 - Volume 26, Number 7—July 2020 - Emerging Infectious Diseases journal - CDC
  • 04/11 OSF | The Small World Network of College Classes: Implications for Epidemic Spread on a University Campus | Cornell
  • 04/12 Face Masks Against COVID-19: An Evidence Review[v1] | Preprints
  • 04/13 Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period | Science
  • 04/13 Universal Screening for SARS-CoV-2 in Women Admitted for Delivery | NEJM
  • 04/15 COVID-19: Hydroxychloroquine & Hypoxic Pneumonia / Timing of Viral Shedding & Transmission / Coinfection with Other Respiratory Pathogens
  • 04/15 Fast spread of COVID-19 in Europe and the US and its implications: even modest public health goals require comprehensive intervention | medRxiv
  • 04/18 Relative disease burdens of COVID-19 and seasonal influenza in New York City, February 1 - April 18, 2020. | medRxiv
  • 04/20 Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor | Nature
  • 04/22 National Covid-19 Testing Action Plan - Rockefeller Foundation [PDF]
  • 04/23 Modeling infectious disease dynamics | Science
  • 04/23 Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19 | medRxiv
  • 04/23 SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes | Nature Medicine
  • 04/24 Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial | Infectious Diseases | JAMA Network Open | JAM
  • 04/24 Aerosol Filtration Efficiency of Common Fabrics Used in Respiratory Cloth Masks | ACS Nano
  • 04/24 Early Release - Asymptomatic SARS-CoV-2 Infection in Household Contacts of a Healthcare Provider, Wuhan, China - Volume 26, Number 8—August 2020 - Emerging Infectious Diseases journal - CDC
  • 04/30 A rapid systematic review of the efficacy of face masks and respirators against coronaviruses and other respiratory transmissible viruses for the community, healthcare workers and sick patients

    May 2020

  • 05/05 Rapid development of an inactivated vaccine candidate for SARS-CoV-2 | Science
  • 05/07 Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial | medRxiv
  • 05/08 Harnessing multiple models for outbreak management | Science discussed here: 05/07 Which COVID-19 models should we use to make policy decisions?
  • 05/08 Impact of climate and public health interventions on the COVID-19 pandemic: a prospective cohort study | CMAJ
  • 05/11 COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions | Infectious Diseases | JAMA | JAMA Network
  • 05/12 The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission | PNAS
  • 05/12 Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study - The Lancet
  • 05/13 An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study - The Lancet
  • 05/13 An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study - The Lancet discussed here: 05/13 Kawasaki-like disease: emerging complication during the COVID-19 pandemic - The Lancet
  • 05/14 Assessment of Deaths From COVID-19 and From Seasonal Influenza | Geriatrics | JAMA Internal Medicine | JAMA Network
  • 05/14 Strong Social Distancing Measures In The United States Reduced The COVID-19 Growth Rate | Health Affairs
  • 05/15 Early Release - Cluster of Coronavirus Disease Associated with Fitness Dance Classes, South Korea - Volume 26, Number 8—August 2020 - Emerging Infectious Diseases journal - CDC
  • 05/20 Nasal ACE2 Levels and COVID-19 in Children | Infectious Diseases | JAMA | JAMA Network
  • 05/25 Tail risk of contagious diseases | Nature Physics
  • 05/29 Differential Effects of Intervention Timing on COVID-19 Spread in the United States | medRxiv

    June 2020

  • 06/01 Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis - The Lancet
  • 06/03 Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review: Annals of Internal Medicine: Vol 0, No 0
  • 06/04 Serodiagnostics for Severe Acute Respiratory Syndrome–Related Coronavirus-2: A Narrative Review: Annals of Internal Medicine: Vol 0, No 0
  • 06/05 False Negative Tests for SARS-CoV-2 Infection — Challenges and Implications | NEJM
  • 06/08 The effect of large-scale anti-contagion policies on the COVID-19 pandemic | Nature discussed here: 06/08 Emergency COVID-19 measures prevented more than 500 million infections, study finds | Berkeley News
  • 06/09 Rationing social contact during the COVID-19 pandemic: Transmission risk and social benefits of US locations | PNAS discussed here: 06/11 Which businesses should be open? | MIT News
  • 06/10 A modelling framework to assess the likely effectiveness of facemasks in combination with ‘lock-down’ in managing the COVID-19 pandemic | Proceedings of the Royal Society A: Mathematical, Physical and Engineering Sciences
  • 06/10 Identifying airborne transmission as the dominant route for the spread of COVID-19 | PNAS
  • 06/11 Eurosurveillance | SARS-CoV-2 infection in farmed minks, the Netherlands, April and May 2020
  • 06/11 Identifying airborne transmission as the dominant route for the spread of COVID-19 | PNAS
  • 06/16 Community Use Of Face Masks And COVID-19: Evidence From A Natural Experiment Of State Mandates In The US | Health Affairs
  • 06/18 Economic Vulnerability of Households With Essential Workers | Health Disparities | JAMA | JAMA Network
  • 06/22 Using influenza surveillance networks to estimate state-specific prevalence of SARS-CoV-2 in the United States | Science Translational Medicine
  • 06/22 Early Release - Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions - Volume 26, Number 9—September 2020 - Emerging Infectious Diseases journal - CDC
  • 06/26 Reducing transmission of SARS-CoV-2 | Science
  • 06/29 Seroconversion of a city: Longitudinal monitoring of SARS-CoV-2 seroprevalence in New York City | medRxiv
  • 06/29 Multisystem Inflammatory Syndrome in U.S. Children and Adolescents | NEJM
  • 06/29 Multisystem Inflammatory Syndrome in Children in New York State | NEJM

    July 2020

  • 07/02 Eurosurveillance | Excess all-cause mortality during the COVID-19 pandemic in Europe – preliminary pooled estimates from the EuroMOMO network, March to April 2020
  • 07/02 The implications of silent transmission for the control of COVID-19 outbreaks | PNAS
  • 07/06 Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study - The Lancet
  • 07/09 Persistent Symptoms in Patients After Acute COVID-19 | Critical Care Medicine | JAMA | JAMA Network
  • 07/09 Socio-economic, environmental impacts of COVID-19 quantified
  • 07/09 Air recirculation role in the infection with COVID-19, lessons learned from Diamond Princess cruise ship | medRxiv
  • 07/10 Tracking the reach of COVID-19 kin loss with a bereavement multiplier applied to the United States | PNAS
  • 07/11 Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection | medRxiv
  • 07/14 An Mrna Vaccine Against Sars Cov 2 — Preliminary Report articles: NEJM.org
  • 07/15 Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial. | medRxiv
  • 07/16 Reconstruction of the full transmission dynamics of COVID-19 in Wuhan | Nature
  • 07/16 Impact of delays on effectiveness of contact tracing strategies for COVID-19: a modelling study - The Lancet Public Health
  • 07/21 The Infectious Nature of Patient-Generated SARS-CoV-2 Aerosol | medRxiv
  • 07/28 Social distancing responses to COVID-19 emergency declarations strongly differentiated by income | PNAS
  • 07/29 Association Between Statewide School Closure and COVID-19 Incidence and Mortality in the US | Infectious Diseases | JAMA | JAMA Network
  • 07/29 Characteristics and Quality of US Nursing Homes Reporting Cases of Coronavirus Disease 2019 (COVID-19) | Geriatrics | JAMA Network Open | JAMA Network

    August 2020

  • 08/01 Long-term patient-reported symptoms of COVID-19: an analysis of social media data | medRxiv
  • 08/03 Use of facemasks during the COVID-19 pandemic - The Lancet Respiratory Medicine
  • 08/04 Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients | medRxiv
  • 08/06 Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea | Infectious Diseases | JAMA Internal Medicine | JAMA Network
  • 08/07 Low-cost measurement of facemask efficacy for filtering expelled droplets during speech | Science Advances
  • 08/07 Interferon responses in viral pneumonias | Science
  • 08/07 Successful Elimination of Covid-19 Transmission in New Zealand | NEJM
  • 08/10 Dental procedure aerosols and COVID-19 - The Lancet Infectious Diseases
  • 08/11 Management of post-acute covid-19 in primary care | The BMJ
  • 08/13 Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2 | medRxiv
  • 08/18 Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure | Annals of Internal Medicine
  • 08/19 Demographic perspectives on the mortality of COVID-19 and other epidemics | PNAS
  • 08/19 Social and behavioral consequences of mask policies during the COVID-19 pandemic | PNAS
  • 08/19 Characterizing superspreading events and age-specific infectiousness of SARS-CoV-2 transmission in Georgia, USA | PNAS
  • 08/21 COVID-19 is, in the end, an endothelial disease | European Heart Journal | Oxford Academic
  • 08/21 Efficacy of Remdesivir in COVID-19 | Infectious Diseases | JAMA | JAMA Network
  • 08/21 Early Release - Asymptomatic Transmission of SARS-CoV-2 on Evacuation Flight - Volume 26, Number 11—November 2020 - Emerging Infectious Diseases journal - CDC
  • 08/24 Full article: Exhaled respiratory particles during singing and talking
  • 08/26 Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis - Clinical Microbiology and Infection
  • 08/26 Population-scale longitudinal mapping of COVID-19 symptoms, behaviour and testing | Nature Human Behaviour
  • 08/27 Misconceptions about weather and seasonality must not misguide COVID-19 response | Nature Communications
  • 08/28 Salivary Detection of COVID-19 | Annals of Internal Medicine
  • 08/28 Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2 | NEJM

    September 2020

  • 09/02 Reduced development of COVID-19 in children reveals molecular checkpoints gating pathogenesis illuminating potential therapeutics | PNAS
  • 09/04 An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction | Nature Communications
  • 09/08 Comparison of Clinical Features of COVID-19 vs Seasonal Influenza A and B in US Children | Infectious Diseases | JAMA Network Open | JAMA Network
  • 09/08 “When Will We Have a Vaccine?” — Understanding Questions and Answers about Covid-19 Vaccination | NEJM
  • 09/08 Facial Masking for Covid-19 — Potential for “Variolation” as We Await a Vaccine | NEJM
  • 09/08 Social and behavioral consequences of mask policies during the COVID-19 pandemic | PNAS
  • 09/08 Demographic perspectives on the mortality of COVID-19 and other epidemics | PNAS
  • 09/09 Clinical Outcomes in Young US Adults Hospitalized With COVID-19 | Critical Care Medicine | JAMA Internal Medicine | JAMA Network
  • 09/09 Use of “normal” risk to improve understanding of dangers of covid-19 | The BMJ
  • 09/09 Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score | The BMJ
  • 09/09 Covid-19 Molecular Diagnostic Testing — Lessons Learned | NEJM
  • 09/10 Trained Innate Immunity, Epigenetics, and Covid-19 | NEJM
  • 09/10 Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study - The Lancet
  • 09/11 COVID-19 and the Path to Immunity | Allergy and Clinical Immunology | JAMA | JAMA Network
  • 09/11 Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection | Infectious Diseases | JAMA Cardiology | JAMA Network
  • 09/14 Seasonal coronavirus protective immunity is short-lasting | Nature Medicine
  • 09/17 Patient-reported outcome measures after COVID-19: a prospective cohort study | European Respiratory Society
  • 09/17 A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity | Nature Communications
  • 09/17 Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong | Nature Medicine
  • 09/18 Artificial intelligence in COVID-19 drug repurposing - The Lancet Digital Health
  • 09/21 COVID-19 in children and young people | Science
  • 09/21 Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients | Science Translational Medicine
  • 09/22 Quantifying and contextualizing the impact of bioRxiv preprints through automated social media audience segmentation
  • 09/22 Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis - PLOS
  • 09/23 National Trends of Cases of COVID-19 in Children Based on US State Health Department Data | American Academy of Pediatrics
  • 09/23 The rise of COVID-19 cases is associated with support for world leaders | PNAS
  • 09/23 Physics of virus transmission by speaking droplets | PNAS
  • 09/25 Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults: A Systematic Review and Meta-analysis | Adolescent Medicine | JAMA Pediatrics | JAMA Network
  • 09/25 Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation | PNAS
  • 09/25 Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study - The Lancet
  • 09/28 Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity | Science
  • 09/28 Effects of ventilation on the indoor spread of COVID-19 | Journal of Fluid Mechanics | Cambridge Core
  • 09/28 Direct detection of SARS-CoV-2 using CRISPR-Cas13a and a mobile phone | medRxiv
  • 09/29 Epidemiology and transmission dynamics of COVID-19 in two Indian states | Science
  • 09/29 A Cytokine Circus with a Viral Ringleader: SARS-CoV-2-Associated Cytokine Storm Syndromes: Trends in Molecular Medicine - Cell
  • 09/29 Genetic mechanisms of critical illness in Covid-19 | medRxiv
  • 09/29 Low risk of SARS-CoV-2 transmission by fomites in real-life conditions - The Lancet Infectious Diseases
  • 09/29 Early Release - Flight-Associated Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Corroborated by Whole-Genome Sequencing - Volume 26, Number 12—December 2020 - Emerging Infectious Diseases journal - CDC
  • 09/30 In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study | The BMJ
  • 09/30 Spinal cord dysfunction after COVID-19 infection - Nature

    October 2020

  • 10/01 Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study - PLOS
  • 10/01 COVID-19 Vaccine Predictions: Using Mathematical Modelling and Expert Opinions to Estimate Timelines and Probabilities of Success of COVID-19 Vaccines | Center For Global Development
  • 10/01 Frontiers | Pandemic Dreams: Network Analysis of Dream Content During the COVID-19 Lockdown | Psychology
  • 10/02 Airborne transmission of SARS-CoV-2 | Science
  • 10/05 Long-term Health Consequences of COVID-19 | Cardiology | JAMA | JAMA Network
  • 10/05 Follow-up of adults with non-critical COVID-19 two months after symptoms' onset - ScienceDirect
  • 10/05 Neuropathology of patients with COVID-19 in Germany: a post-mortem case series - The Lancet Neurology
  • 10/06 Children and Adolescents With SARS-CoV-2 Infection Epidemiology, Clinical Course and Viral Loads - The Pediatric Infectious Disease Journal
  • 10/06 Symptoms and Transmission of SARS-CoV-2 among Children—Utah and Wisconsin, March–May 2020 | American Academy of Pediatrics
  • 10/06 SARS-CoV-2-specific T-cells in unexposed humans: presence of cross-reactive memory cells does not equal protective immunity | Signal Transduction and Targeted Therapy
  • 10/06 Cross-reactive memory T cells and herd immunity to SARS-CoV-2 | Nature Reviews Immunology
  • 10/06 Characteristics of SARS-CoV-2 and COVID-19 | Nature Reviews Microbiology
  • 10/06 Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases | PNAS
  • 10/07 The effect of temperature on persistence of SARS-CoV-2 on common surfaces | Virology Journal | Full Text
  • 10/07 Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19 | Nature Immunology
  • 10/08 Characteristics of Hospitalized Children With SARS-CoV-2 in the New York City Metropolitan Area - PubMed
  • 10/08 SARS-CoV-2 disrupts splicing, translation, and protein trafficking to suppress host defenses: Cell
  • 10/08 Remdesivir for the Treatment of Covid-19 — Final Report | NEJM
  • 10/08 Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study - The Lancet Respiratory Medicine
  • 10/09 Economic hardship and mental health complaints during COVID-19 | PNAS
  • 10/10 Convalescent plasma for patients with severe COVID-19: a matched cohort study | Clinical Infectious Diseases | Oxford Academic
  • 10/11 Global projections of potential lives saved from COVID-19 through universal mask use | medRxiv
  • 10/12 Excess Deaths From COVID-19 and Other Causes, March-July 2020 | Cardiology | JAMA | JAMA Network
  • 10/12 Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center in New York City | Infectious Diseases | JAMA Pediatrics | JAMA Network
  • 10/12 SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies | Nature
  • 10/12 The role of environmental factors on transmission rates of the COVID-19 outbreak: an initial assessment in two spatial scales | Scientific Reports - Nature
  • 10/12 Seasonality and uncertainty in global COVID-19 growth rates | PNAS
  • 10/12 Genomic evidence for reinfection with SARS-CoV-2: a case study - The Lancet Infectious Diseases
  • 10/13 Sudden irreversible hearing loss post COVID-19 | BMJ Case Reports
  • 10/13 Regeneron’s Antibodies Prevent and Treat SARS-CoV-2 Infection in Monkeys
  • 10/13 SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates - The Lancet
  • 10/13 COVID-19 in New Zealand and the impact of the national response: a descriptive epidemiological study - The Lancet Public Health
  • 10/15 Synthesis and systematic review of reported neonatal SARS-CoV-2 infections | Nature Communications
  • 10/16 Emergency Use Authorization of Covid Vaccines — Safety and Efficacy Follow-up Considerations | NEJM
  • 10/19 Herd Immunity and Implications for SARS-CoV-2 Control | JAMA | JAMA Network
  • 10/19 Asymptomatic and Presymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates in a Multistate Sample of Skilled Nursing Facilities | Geriatrics | JAMA Internal Medicine | JAMA Network
  • 10/19 Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity | Science
  • 10/19 Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate | Science
  • 10/20 Numerical investigation of aerosol transport in a classroom with relevance to COVID-19: Physics of Fluids: Vol 32, No 10
  • 10/20 Building Trust to Achieve Confidence in COVID-19 Vaccines | Infectious Diseases | JAMA Network Open | JAMA Network
  • 10/20 Factors Associated With US Adults’ Likelihood of Accepting COVID-19 Vaccination | Infectious Diseases | JAMA Network Open | JAMA Network
  • 10/20 Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study | The BMJ
  • 10/20 Eurosurveillance | A large national outbreak of COVID-19 linked to air travel, Ireland, summer 2020 - Eurosurveillance
  • 10/21 Early Release - Susceptibility of Raccoon Dogs for Experimental SARS-CoV-2 Infection - Volume 26, Number 12—December 2020 - Emerging Infectious Diseases journal - CDC
  • 10/22 Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial) | The BMJ
  • 10/23 Trends in COVID-19 Risk-Adjusted Mortality Rates | Journal of Hospital Medicine
  • 10/24 Identification of required host factors for SARS-CoV-2 infection in human cells: Cell
  • 10/26 Preventing the Spread of SARS-CoV-2 With Masks and Other “Low-tech” Interventions | Infectious Diseases | JAMA | JAMA Network
  • 10/26 Return to Play for Athletes After Coronavirus Disease 2019 Infection—Making High-Stakes Recommendations as Data Evolve | Infectious Diseases | JAMA Cardiology | JAMA Network
  • 10/26 Coronavirus Disease 2019 and the Athletic Heart: Emerging Perspectives on Pathology, Risks, and Return to Play | Infectious Diseases | JAMA Cardiology | JAMA Network
  • 10/26 Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans | Nature Microbiology
  • 10/27 Aerosol persistence in relation to possible transmission of SARS-CoV-2: Physics of Fluids: Vol 32, No 10
  • 10/27 COVID-19 associated arterial ischaemic stroke and multisystem inflammatory syndrome in children: a case report - The Lancet Child & Adolescent Health
  • 10/27 What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2 - The Lancet Infectious Diseases
  • 10/28 Risk of hospital admission with coronavirus disease 2019 in healthcare workers and their households: nationwide linkage cohort study | The BMJ
  • 10/28 Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19: Cell
  • 10/28 SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19 | NEJM
  • 10/29 Wearable sensor data and self-reported symptoms for COVID-19 detection | Nature Medicine
  • 10/30 Association between SARS-CoV-2 infection, exposure risk and mental health among a cohort of essential retail workers in the USA | Occupational & Environmental Medicine
  • 10/30 The Effects of Large Group Meetings on the Spread of COVID-19: The Case of Trump Rallies by B. Douglas Bernheim, Nina Buchmann, Zach Freitas-Groff, Sebastián Otero :: SSRN
  • 10/30 SARS-CoV-2 direct cardiac damage through spike-mediated cardiomyocyte fusion | Research Square

    November 2020

  • 11/02 Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19 | Science Translational Medicine
  • 11/02 Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection | bioRxiv
  • 11/03 Dispersion of evaporating cough droplets in tropical outdoor environment: Physics of Fluids: Vol 32, No 11
  • 11/03 Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production: Cell
  • 11/03 Revealing fine-scale spatiotemporal differences in SARS-CoV-2 introduction and spread | Nature Communications
  • 11/03 Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City | Nature
  • 11/04 Lack of antibodies to SARS-CoV-2 in a large cohort of previously infected persons | Clinical Infectious Diseases | Oxford Academic
  • 11/04 An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike | Science
  • 11/04 Case Study: Prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised cancer patient.: Cell
  • 11/04 High Prevalence of Pericardial Involvement in College Student-Athletes Recovering From COVID-19 | JACC: Cardiovascular Imaging
  • 11/05 Differential effects of intervention timing on COVID-19 spread in the United States | Science Advances
  • 11/05 Preexisting and de novo humoral immunity to SARS-CoV-2 in humans | Science
  • 11/05 Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum | Nature Immunology
  • 11/06 Acute Kidney Injury in a National Cohort of Hospitalized US Veterans with COVID-19 | American Society of Nephrology
  • 11/06 Epidemiology and transmission dynamics of COVID-19 in two Indian states | Science
  • 11/09 Real-time, interactive website for US-county-level COVID-19 event risk assessment | Nature Human Behaviour
  • 11/09 Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids | Nature Medicine
  • 11/09 Characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK: a prospective national cohort study using active surveillance - The Lancet Child & Adolescent Health
  • 11/10 Speed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug Administration | Vaccination | JAMA Internal Medicine | JAMA Network
  • 11/10 Mobility network models of COVID-19 explain inequities and inform reopening | Nature
  • 11/11 Sixty-Day Outcomes Among Patients Hospitalized With COVID-19 | Annals of Internal Medicine
  • 11/11 Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers | Nature Structural & Molecular Biology
  • 11/12 The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19) | Scientific Reports
  • 11/13 Enhancing host cell infection by SARS-CoV-2 | Science
  • 11/13 Real-time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles: Cell Host & Microbe
  • 11/13 SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 are Expressed in the Microvasculature and Ducts of Human Pancreas but are Not Enriched in β Cells: Cell Metabolism
  • 11/14 Staying sane in our new COVID-19 world - The Lancet
  • 11/16 Trends in Outpatient Care Delivery and Telemedicine During the COVID-19 Pandemic in the US | Infectious Diseases | JAMA Internal Medicine | JAMA Network
  • 11/16 Diaphragm Pathology in Critically Ill Patients With COVID-19 and Postmortem Findings From 3 Medical Centers | Critical Care Medicine | JAMA Internal Medicine | JAMA Network
  • 11/16 COVID-19-associated Non-Occlusive Fibrin Microthrombi in the Heart | Circulation
  • 11/16 Immunological memory to SARS-CoV-2 assessed for greater than six months after infection | bioRxiv
  • 11/16 Ranking the effectiveness of worldwide COVID-19 government interventions | Nature Human Behaviour
  • 11/17 Ensuring vaccine safety | Science
  • 11/17 Expecting the unexpected with COVID-19 vaccines - The Lancet Infectious Diseases
  • 11/18 The known unknowns of T cell immunity to COVID-19 | Science Immunology
  • 11/18 Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers: A Randomized Controlled Trial: Annals of Internal Medicine: Vol 0, No 0 - ACP Journals
  • 11/18 COVID-19-associated olfactory dysfunction reveals SARS-CoV-2 neuroinvasion and persistence in the olfactory system | bioRxiv
  • 11/18 Antibodies to SARS-CoV-2 are associated with protection against reinfection | medRxiv
  • 11/18 Pre-symptomatic detection of COVID-19 from smartwatch data | Nature Biomedical Engineering
  • 11/18 Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19 | Nature Immunology
  • 11/18 Event-specific interventions to minimize COVID-19 transmission | PNAS
  • 11/18 Age and frailty in COVID-19 vaccine development - The Lancet
  • 11/19 Ct values and infectivity of SARS-CoV-2 on surfaces - The Lancet Infectious Diseases
  • 11/19 SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis - The Lancet Microbe
  • 11/20 Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening | Science Advances
  • 11/20 Air-Filtering Masks for Respiratory Protection from PM2.5 and Pandemic Pathogens: One Earth
  • 11/23 Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2 | Science
  • 11/23 Functional SARS-CoV-2-specific immune memory persists after mild COVID-19: Cell
  • 11/24 Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020 | Infectious Diseases | JAMA Internal Medicine | JAMA Network
  • 11/24 Antibodies, Immunity, and COVID-19 | Infectious Diseases | JAMA Internal Medicine | JAMA Network
  • 11/24 SARS-CoV-2 receptors and entry genes are expressed in the human olfactory neuroepithelium and brain: iScience
  • 11/24 A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19 | NEJM
  • 11/24 A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia | NEJM
  • 11/24 Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion | PNAS
  • 11/26 Nucleic Acid-Based Technologies Targeting Coronaviruses: Trends in Biochemical Sciences
  • 11/26 Rethinking Covid-19 Test Sensitivity — A Strategy for Containment | NEJM
  • 11/27 Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate | Science
  • 11/27 SARS-CoV-2 and the risk of Parkinson's disease: facts and fantasy - The Lancet Neurology
  • 11/28 The effectiveness of population-wide, rapid antigen test based screening in reducing SARS-CoV-2 infection prevalence in Slovakia | CMMID Repository
  • 11/28 A tribute to some of the doctors who died from COVID-19 - The Lancet
  • 11/30 Frontiers | Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection | Immunology
  • 11/30 COVID-19 in a case previously infected with MERS-CoV: No cross immunity - Journal of Infection
  • 11/30 Toward superhuman SARS-CoV-2 immunity? | Nature Medicine
  • 11/30 Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19 | Nature Neuroscience

    December 2020

  • 12/01 Post-infectious inflammatory disease in MIS-C features elevated cytotoxicity signatures and autoreactivity that correlates with severity | medRxiv
  • 12/01 Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer | NEJM
  • 12/02 Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results - PubMed
  • 12/02 Reversible Myocardial Injury Associated With SARS-CoV-2 in an Infant | JACC: Case Reports
  • 12/02 Placebo-Controlled Trials of Covid-19 Vaccines — Why We Still Need Them | NEJM
  • 12/03 Fast detection of SARS-CoV-2 RNA via the integration of plasmonic thermocycling and fluorescence detection in a portable device | Nature Biomedical Engineering
  • 12/03 Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host | NEJM
  • 12/03 Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination | NEJM
  • 12/03 Cytokine Storm | NEJM
  • 12/03 Face masks considerably reduce COVID-19 cases in Germany | PNAS
  • 12/04 Amplification-free detection of SARS-CoV-2 with CRISPR-Cas13a and mobile phone microscopy: Cell
  • 12/04 Correlates of protection against SARS-CoV-2 in rhesus macaques | Nature
  • 12/04 Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison | Nature Immunology
  • 12/07 IgA dominates the early neutralizing antibody response to SARS-CoV-2 | Science Translational Medicine
  • 12/07 Enhanced SARS-CoV-2 neutralization by dimeric IgA | Science Translational Medicine
  • 12/07 Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis | The BMJ
  • 12/07 Model-informed COVID-19 vaccine prioritization strategies by age and serostatus | medRxiv
  • 12/07 Effect of internationally imported cases on internal spread of COVID-19: a mathematical modelling study - The Lancet Public Health
  • 12/08 iGenomics: Comprehensive DNA sequence analysis on your Smartphone | GigaScience | Oxford Academic
  • 12/08 Effect of sneezing on the flow around a face shield: Physics of Fluids: Vol 32, No 12
  • 12/08 Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic | Science
  • 12/08 Simultaneous COVID-19 in Homozygous Twins | Annals of Internal Medicine
  • 12/08 Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Randomized Trial: Annals of Internal Medicine: Vol 0, No 0
  • 12/08 Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet
  • 12/08 SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England - The Lancet Infectious Diseases
  • 12/09 Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants | Occupational & Environmental Medicine
  • 12/09 Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2 | Science Translational Medicine
  • 12/10 Evaluation of Cloth Masks and Modified Procedure Masks as Personal Protective Equipment for the Public During the COVID-19 Pandemic | Infectious Diseases | JAMA Internal Medicine | JAMA Network
  • 12/10 Using Cardiovascular Cells from Human Pluripotent Stem Cells for COVID-19 Research: Why the Heart Fails: Stem Cell Reports
  • 12/11 The kinetics of humoral response and its relationship with the disease severity in COVID-19 | Communications Biology
  • 12/11 Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2 | PNAS
  • 12/12 Is my cough COVID-19? - The Lancet
  • 12/13 SARS-CoV-2 RNA reverse-transcribed and integrated into the human genome | bioRxiv
  • 12/14 Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis | Global Health | JAMA Network Open | JAMA Network
  • 12/15 Effects of mask-wearing on the inhalability and deposition of airborne SARS-CoV-2 aerosols in human upper airway: Physics of Fluids: Vol 32, No 12
  • 12/15 Effects of space sizes on the dispersion of cough-generated droplets from a walking person: Physics of Fluids: Vol 32, No 12
  • 12/15 Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis | The BMJ
  • 12/15 COVID-19 neutralizing antibodies predict disease severity and survival: Cell
  • 12/15 Nursing home staff networks and COVID-19 | PNAS
  • 12/15 Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study - The Lancet Child & Adolescent Health
  • 12/15 SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study - The Lancet Infectious Diseases
  • 12/16 All-Cause Excess Mortality and COVID-19–Related Mortality Among US Adults Aged 25-44 Years, March-July 2020 | Infectious Diseases | JAMA | JAMA Network
  • 12/16 The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice | Nature Neuroscience
  • 12/16 Emergence of a Highly Fit SARS-CoV-2 Variant | NEJM
  • 12/17 COVID-19 Myocardial Pathology Evaluation in AthleTEs with Cardiac Magnetic Resonance (COMPETE CMR) | Circulation
  • 12/17 A Crisp(r) New Perspective on SARS-CoV-2 Biology: Cell
  • 12/17 Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses | Nature Medicine
  • 12/17 T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial | Nature Medicine
  • 12/17 Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study - The Lancet Respiratory Medicine
  • 12/18 Kinetics of antibody responses dictate COVID-19 outcome | medRxiv
  • 12/18 Infectivity of asymptomatic versus symptomatic COVID-19 - The Lancet
  • 12/20 Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations - nCoV-2019 Genomic Epidemiology - Virological
  • 12/20 Threat Assessment Brief: Rapid increase of a SARS-CoV-2 variant with multiple spike protein mutations observed in the United Kingdom - ECDC
  • 12/21 Excess Mortality in California During the Coronavirus Disease 2019 Pandemic, March to August 2020 | Infectious Diseases | JAMA Internal Medicine | JAMA Network
  • 12/21 Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study - The Lancet Microbe
  • 12/22 Variation in US Hospital Mortality Rates for Patients Admitted With COVID-19 During the First 6 Months of the Pandemic | Infectious Diseases | JAMA Internal Medicine | JAMA Network
  • 12/22 Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid: Immunity
  • 12/22 COVID-19 and the Swedish enigma - The Lancet
  • 12/23 Assessment of Air Contamination by SARS-CoV-2 in Hospital Settings | Infectious Diseases | JAMA Network Open | JAMA Network
  • 12/23 SARS-CoV-2 mutations among minks show reduced lethality and infectivity to humans | bioRxiv
  • 12/23 Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers | NEJM
  • 12/24 Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact | medRxiv
  • 12/25 Reverse Engineering the source code of the BioNTech/Pfizer SARS-CoV-2 Vaccine - Articles
  • 12/25 SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity: Med
  • 12/28 One Year Later, How Does COVID-19 Affect Children? | Infectious Diseases | JAMA Pediatrics | JAMA Network
  • 12/28 Superspreading in early transmissions of COVID-19 in Indonesia | Scientific Reports
  • 12/29 Assessment of Neutrophil Extracellular Traps in Coronary Thrombus of a Case Series of Patients With COVID-19 and Myocardial Infarction | Acute Coronary Syndromes | JAMA Cardiology | JAMA Network
  • 12/29 Update Alert 4: Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings | Annals of Internal Medicine
  • 12/29 Masks and Face Coverings for the Lay Public: A Narrative Update: Annals of Internal Medicine: Vol 0, No 0
  • 12/30 Fluid dynamics of COVID-19 airborne infection suggests urgent data for a scientific design of social distancing | Scientific Reports
  • 12/30 Microvascular Injury in the Brains of Patients with Covid-19 | NEJM
  • 12/30 Neutralizing Antibody LY-CoV555 for Outpatient Covid-19 | NEJM
  • 12/30 Maintaining Safety with SARS-CoV-2 Vaccines | NEJM

    January 2021

  • 01/01 Airflows inside passenger cars and implications for airborne disease transmission | Science Advances
  • 01/02 Mutations arising in SARS-CoV-2 spike on sustained human-to-human transmission and human-to-animal passage - SARS-CoV-2 coronavirus - Virological
  • 01/04 Risk Factors Associated With All-Cause 30-Day Mortality in Nursing Home Residents With COVID-19 | Dementia and Cognitive Impairment | JAMA Internal Medicine | JAMA Network
  • 01/05 Endemic SARS-CoV-2 will maintain post-pandemic immunity | Nature Reviews Immunology
  • 01/05 Early Release - Genomic Evidence of In-Flight Transmission of SARS-CoV-2 Despite Predeparture Testing - Volume 27, Number 3—March 2021 - Emerging Infectious Diseases journal - CDC
  • 01/06 Genetic Variants of SARS-CoV-2—What Do They Mean? | Infectious Diseases | JAMA | JAMA Network
  • 01/06 Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection | Science
  • 01/07 The value of decreasing the duration of the infectious period of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection - PLOS
  • 01/07 COVID-19 vasculitis and novel vasculitis mimics - The Lancet Rheumatology
  • 01/08 A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis | Science
  • 01/08 Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK | Science
  • 01/08 Findings from Cardiovascular Evaluation of NCAA Division I Collegiate Student-Athletes after Asymptomatic or Mildly Symptomatic SARS-CoV-2 Infection | medRxiv
  • 01/11 Immunological characteristics govern the transition of COVID-19 to endemicity | Science
  • 01/11 Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice | Science
  • 01/11 A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection | Nature Genetics
  • 01/11 The distribution of cellular turnover in the human body | Nature Medicine
  • 01/11 Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals | Nature Medicine
  • 01/11 A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent | Nature Structural & Molecular Biology
  • 01/11 Retail store customer flow and COVID-19 transmission | PNAS
  • 01/12 MuSK Antibody–Associated Myasthenia Gravis With SARS-CoV-2 Infection: A Case Report | Annals of Internal Medicine
  • 01/12 The Sensitivity and Costs of Testing for SARS-CoV-2 Infection With Saliva Versus Nasopharyngeal Swabs: A Systematic Review and Meta-analysis: Annals of Internal Medicine: Vol 0, No 0 - ACP Journals
  • 01/12 Adaptive immunity to SARS-CoV-2 and COVID-19: Cell
  • 01/12 First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020 - The Lancet Infectious Diseases
  • 01/13 Messenger RNA vaccines against SARS-CoV-2: Cell
  • 01/13 Immune determinants of COVID-19 disease presentation and severity | Nature Medicine
  • 01/13 Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19 | NEJM
  • 01/13 Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine | NEJM
  • 01/14 Evaluation for Myocarditis in Competitive Student Athletes Recovering From Coronavirus Disease 2019 With Cardiac Magnetic Resonance Imaging | Cardiology | JAMA Cardiology | JAMA Network
  • 01/14 SARS-CoV-2 antibody testing for estimating COVID-19 prevalence in the population: Cell Reports Medicine
  • 01/14 Long COVID in the skin: a registry analysis of COVID-19 dermatological duration - The Lancet Infectious Diseases
  • 01/14 Public health surveillance of infectious diseases: beyond point mutations - The Lancet Microbe
  • 01/15 Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2: A Systematic Review and Meta-analysis | Infectious Diseases | JAMA Internal Medicine | JAMA Network
  • 01/15 Isolation of SARS-CoV-2 from the air in a car driven by a COVID patient with mild illness | medRxiv
  • 01/15 Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data - The Lancet Respiratory Medicine
  • 01/18 Sociodemographic disparities in energy insecurity among low-income households before and during the COVID-19 pandemic | Nature Energy
  • 01/18 Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study - The Lancet Infectious Diseases
  • 01/19 mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants | bioRxiv
  • 01/19 Vaccinology in the post−COVID-19 era | PNAS
  • 01/19 Mask-wearing and control of SARS-CoV-2 transmission in the USA: a cross-sectional study - The Lancet Digital Health
  • 01/21 Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8+ T cells | Science Immunology
  • 01/21 Model-informed COVID-19 vaccine prioritization strategies by age and serostatus | Science
  • 01/21 Optimizing age-specific vaccination | Science
  • 01/22 Sex differences in immune responses | Science
  • 01/22 Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody | Science
  • 01/22 The Proportion of SARS-CoV-2 Infections That Are Asymptomatic: A Systematic Review: Annals of Internal Medicine: Vol 0, No 0
  • 01/23 B cell memory: Understanding COVID-19: Immunity
  • 01/23 B cell memory: understanding COVID-19: Immunity
  • 01/25 Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody | Science
  • 01/25 Global absence and targeting of protective immune states in severe COVID-19 | Nature
  • 01/25 Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis | Nature
  • 01/25 Early warnings of COVID-19 outbreaks across Europe from social media | Scientific Reports
  • 01/26 Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases: Cell Reports Medicine
  • 01/26 Antibodies, epicenter of SARS-CoV-2 immunology | Cell Death & Differentiation
  • 01/26 An evidence review of face masks against COVID-19 | PNAS
  • 01/27 The case against delaying SARS-CoV-2 mRNA vaccine boosting doses | Clinical Infectious Diseases | Oxford Academic
  • 01/27 Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K, and N501Y variants by BNT162b2 vaccine-elicited sera | bioRxiv
  • 01/27 Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19 | NEJM
  • 01/27 Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence - The Lancet
  • 01/28 Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera | Science
  • 01/28 Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity: Cell
  • 01/28 SARS-CoV-2 testing for public health use: core principles and considerations for defined use settings - The Lancet Global Health
  • 01/29 Translating viral vaccines into immunity | Science
  • 01/29 Insights from SARS-CoV-2 sequences | Science
  • 01/29 Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response: Cell Host & Microbe
  • 01/29 Public health actions to control new SARS-CoV-2 variants: Cell
  • 01/29 Leveraging the antiviral type-I interferon system as a first line defense against SARS-CoV-2 pathogenicity: Immunity
  • 01/29 Robust spike antibody responses and increased reactogenicity in seropositive individuals after a single dose of SARS-CoV-2 mRNA vaccine | medRxiv
  • 01/30 SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses - EBioMedicine

    February 2021

  • 02/01 Age groups that sustain resurging COVID-19 epidemics in the United States | Science
  • 02/02 Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape | Science
  • 02/02 Naive human B cells can neutralize SARS-CoV-2 through recognition of its receptor binding domain | bioRxiv
  • 02/02 Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity | Nature Immunology
  • 02/02 Sixteen novel lineages of SARS-CoV-2 in South Africa | Nature Medicine
  • 02/02 Timing matters when correcting fake news | PNAS
  • 02/02 Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia - The Lancet
  • 02/02 Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study - The Lancet Infectious Diseases
  • 02/02 Understanding the drivers of transmission of SARS-CoV-2 - The Lancet Infectious Diseases
  • 02/03 Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents | Nature Biotechnology
  • 02/03 SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas | Nature Metabolism
  • 02/04 Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Nasopharyngeal Viral Load in Patients With COVID-19: A Randomized Clinical Trial | Infectious Diseases | JAMA Otolaryngology–Head & Neck Surgery | JAMA Network
  • 02/04 Comparative cost-effectiveness of SARS-CoV-2 testing strategies in the USA: a modelling study - The Lancet Public Health
  • 02/05 Cardiac arrest occurrence during successive waves of the COVID-19 pandemic: direct and indirect consequences | European Heart Journal | Oxford Academic
  • 02/05 Antibodies elicited by SARS-CoV-2 infection and boosted by vaccination neutralize an emerging variant and SARS-CoV-1 | medRxiv
  • 02/05 SARS-CoV-2 evolution during treatment of chronic infection | Nature
  • 02/05 COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics - The Lancet Public Health
  • 02/05 Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial - The Lancet Respiratory Medicine
  • 02/07 Genomic epidemiology identifies emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States | medRxiv
  • 02/08 SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study - The Lancet Child & Adolescent Health
  • 02/09 Simulation-based study of COVID-19 outbreak associated with air-conditioning in a restaurant: Physics of Fluids: Vol 33, No 2
  • 02/09 Prevalence and Outcomes of SARS-CoV-2 Infection Among Migrant Workers in Singapore | Global Health | JAMA | JAMA Network
  • 02/09 Public Health Interventions, Epidemic Growth, and Regional Variation of the 1918 Influenza Pandemic Outbreak in a Swiss Canton and Its Greater Regions | Annals of Internal Medicine
  • 02/09 A SARS-CoV-2 Cluster in an Acute Care Hospital | Annals of Internal Medicine
  • 02/09 Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection: Cell
  • 02/09 COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses: Immunity
  • 02/09 Poor antigen-specific responses to the second BNT162b2 mRNA vaccine dose in SARS-CoV-2-experienced individuals | medRxiv
  • 02/09 COVID-19 Modeling and the Path to Herd Immunity - Medscape
  • 02/09 The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome | PNAS
  • 02/10 Severe reinfection with South African SARS-CoV-2 variant 501Y.V2: A case report | Clinical Infectious Diseases | Oxford Academic
  • 02/10 Effectiveness of Mask Wearing to Control Community Spread of SARS-CoV-2 | Infectious Diseases | JAMA | JAMA Network
  • 02/10 Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South Africa | medRxiv
  • 02/10 Public policy and health in the Trump era - The Lancet
  • 02/10 Effect of the new SARS-CoV-2 variant B.1.1.7 on children and young people - The Lancet Child & Adolescent Health
  • 02/11 The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types | eLife
  • 02/11 Emergence of a Novel SARS-CoV-2 Variant in Southern California | Public Health | JAMA | JAMA Network
  • 02/11 The role of children in the spread of COVID-19: Using household data from Bnei Brak, Israel, to estimate the relative susceptibility and infectivity of children - PLOS
  • 02/11 Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors - PLOS
  • 02/11 Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study | The BMJ
  • 02/11 Hydrating the respiratory tract: an alternative explanation why masks lower severity of COVID-19: Biophysical Journal
  • 02/12 Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021 | Allergy and Clinical Immunology | JAMA | JAMA Network
  • 02/12 Assessing Brain Capillaries in Coronavirus Disease 2019 | Infectious Diseases | JAMA Neurology | JAMA Network
  • 02/12 Single-domain antibodies make a difference | Science
  • 02/12 Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice | Science
  • 02/12 A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection | bioRxiv
  • 02/12 Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection: Cell
  • 02/15 Viral load of SARS-CoV-2 in adults during the first and second wave of COVID-19 pandemic in Houston, TX: the potential of the super-spreader | The Journal of Infectious Diseases | Oxford Academic
  • 02/15 OSF Preprints | Superspreaders drive the largest outbreaks of hospital onset COVID-19 infection
  • 02/15 Diagnostics for SARS-CoV-2 infections | Nature Materials
  • 02/15 Interleukin-6 Receptor Inhibition in Covid-19 — Cooling the Inflammatory Soup | NEJM
  • 02/16 Densely sampled viral trajectories suggest longer duration of acute infection with B.1.1.7 variant relative to non-B.1.1.7 SARS-CoV-2 - Harvard
  • 02/16 Ocular MRI Findings in Patients with Severe COVID-19: A Retrospective Multicenter Observational Study | Radiology
  • 02/16 COVID-19 and the human innate immune system: Cell
  • 02/17 Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study | SpringerLink
  • 02/17 Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets | Science
  • 02/17 Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine | NEJM
  • 02/17 Neutralizing Activity of BNT162b2-Elicited Serum — Preliminary Report | NEJM
  • 02/17 Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine — Preliminary Report | NEJM
  • 02/18 Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera: Cell
  • 02/18 Circulating SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity | medRxiv
  • 02/18 Could mutations of SARS-CoV-2 suppress diagnostic detection? | Nature Biotechnology
  • 02/19 Immunogenicity of clinically relevant SARS-CoV-2 vaccines in non-human primates and humans | Science Advances
  • 02/19 Sequelae in Adults at 6 Months After COVID-19 Infection | Infectious Diseases | JAMA Network Open | JAMA Network
  • 02/19 Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection | Leukemia | Nature
  • 02/19 Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet
  • 02/19 Delayed-onset myocarditis following COVID-19 - The Lancet Respiratory Medicine
  • 02/23 Relationship between human exhalation diffusion and posture in face-to-face scenario with utterance: Physics of Fluids: Vol 33, No 2
  • 02/23 Viral load and contact heterogeneity predict SARS-CoV-2 transmission and super-spreading events | eLife
  • 02/23 Prolonged evolution of the human B cell response to SARS-CoV-2 infection | Science Immunology
  • 02/23 SARS-CoV-2 lineage B.1.526 emerging in the New York region detected by software utility created to query the spike mutational landscape | bioRxiv
  • 02/23 Extremely potent human monoclonal antibodies from COVID-19 convalescent patients: Cell
  • 02/23 Mechanistic transmission modeling of COVID-19 on the Diamond Princess cruise ship demonstrates the importance of aerosol transmission | PNAS
  • 02/23 Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort | PNAS
  • 02/23 Pandemic precarity: COVID-19 is exposing and exacerbating inequalities in the American heartland | PNAS
  • 02/23 Exhaled aerosol increases with COVID-19 infection, age, and obesity | PNAS
  • 02/24 Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection - Authorea
  • 02/24 BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting | NEJM
  • 02/25 Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals - The Lancet
  • 02/25 Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine - The Lancet
  • 02/26 SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis | JACC: Basic to Translational Science
  • 02/26 SARS-CoV-2 spike D614G change enhances replication and transmission | Nature

    March 2021

  • 03/01 Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2 | Vaccination | JAMA | JAMA Network
  • 03/01 COVID-19 -- exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study | Wellcome Open Research
  • 03/01 Negligible impact of SARS-CoV-2 variants on CD4+ and CD8+ T cell reactivity in COVID-19 exposed donors and vaccinees | bioRxiv
  • 03/02 Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19 | Science Immunology
  • 03/02 High-Throughput Wastewater SARS-CoV-2 Detection Enables Forecasting of Community Infection Dynamics in San Diego County | mSystems
  • 03/02 Increased Resistance of SARS-CoV-2 Variant P.1 to Antibody Neutralization | bioRxiv
  • 03/02 ‘nAb’ the self-reactive activity in the COVID-19 combat | Signal Transduction and Targeted Therapy
  • 03/02 The prevalence of antibodies to SARS-CoV-2 among blood donors in China | Nature Communications
  • 03/02 Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics | Nature Medicine
  • 03/02 SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma | Nature Medicine
  • 03/02 Quantifying asymptomatic infection and transmission of COVID-19 in New York City using observed cases, serology, and testing capacity | PNAS
  • 03/02 The effects of school closures on SARS-CoV-2 among parents and teachers | PNAS
  • 03/02 The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2 | PNAS
  • 03/02 A genomic region associated with protection against severe COVID-19 is inherited from Neandertals | PNAS
  • 03/02 An interactive website tracking COVID-19 vaccine development - The Lancet Global Health
  • 03/03 Filtering Facepiece Respirator (N95 Respirator) Reprocessing: A Systematic Review | Infectious Diseases | JAMA | JAMA Network
  • 03/03 Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England | Science
  • 03/03 Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates | Science Translational Medicine
  • 03/03 SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines: Cell Host & Microbe
  • 03/03 Preliminary Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.351 Variant | medRxiv
  • 03/03 Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2 | NEJM
  • 03/03 Multisystem inflammatory syndrome in a neonate, temporally associated with prenatal exposure to SARS-CoV-2: a case report - The Lancet Child & Adolescent Health
  • 03/04 Prevalence of Inflammatory Heart Disease Among Professional Athletes With Prior COVID-19 Infection Who Received Systematic Return-to-Play Cardiac Screening | Cardiology | JAMA Cardiology | JAMA Network
  • 03/04 SARS-CoV-2 on Ocular Surfaces in a Cohort of Patients With COVID-19 From the Lombardy Region, Italy | Infectious Diseases | JAMA Ophthalmology | JAMA Network
  • 03/04 Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial - The Lancet Respiratory Medicine
  • 03/04 Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Respiratory Medicine
  • 03/04 IL-6 blockade for COVID-19: a global scientific call to arms - The Lancet Respiratory Medicine
  • 03/05 An early warning approach to monitor COVID-19 activity with multiple digital traces in near real time | Science Advances
  • 03/05 Longitudinal antibody repertoire in "mild" versus "severe" COVID-19 patients reveals immune markers associated with disease severity and resolution | Science Advances
  • 03/06 The impact of Spike mutations on SARS-CoV-2 neutralization: Cell Reports
  • 03/06 Longitudinal Analysis Reveals Distinct Antibody and Memory B Cell Responses in SARS-CoV2 Naïve and Recovered Individuals Following mRNA Vaccination | medRxiv
  • 03/08 Acute Allergic Reactions to mRNA COVID-19 Vaccines | Allergy and Clinical Immunology | JAMA | JAMA Network
  • 03/08 Higher COVID-19 vaccination rates are linked to decreased county-level COVID-19 incidence across USA | medRxiv
  • 03/08 Long-term clinical, virological and immunological outcomes in patients hospitalized for COVID-19: antibody response predicts long COVID. | medRxiv
  • 03/08 Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2 | Nature Genetics
  • 03/08 Neutralizing Activity of BNT162b2-Elicited Serum | NEJM
  • 03/08 Clinical Characteristics, Activity Levels and Mental Health Problems in Children with Long COVID: A Survey of 510 Children[v1] | Preprints
  • 03/08 18Fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine - The Lancet
  • 03/08 Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis - The Lancet Global Health
  • 03/09 Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes | Science
  • 03/09 SARS-CoV-2 within-host diversity and transmission | Science
  • 03/09 The cytosolic DNA sensor cGAS recognizes neutrophil extracellular traps | Science Signaling
  • 03/09 Clinical and Economic Effects of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission | Annals of Internal Medicine
  • 03/09 The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies that target both the NTD and the RBD | medRxiv
  • 03/09 Emergence of a SARS-CoV-2 variant of concern with mutations in spike glycoprotein | Nature
  • 03/10 Impact of the COVID-19 Vaccine on Asymptomatic Infection Among Patients Undergoing Pre-Procedural COVID-19 Molecular Screening | Clinical Infectious Diseases | Oxford Academic
  • 03/10 Effectiveness of three versus six feet of physical distancing for controlling spread of COVID-19 among primary and secondary students and staff: A retrospective, state-wide cohort study | Clinical Infectious Diseases | Oxford Academic
  • 03/10 Infodemics: Do healthcare professionals detect corona-related false news stories better than students? - PLOS
  • 03/10 Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study | The BMJ
  • 03/10 Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study | The BMJ
  • 03/10 Virus vaccines: proteins prefer prolines: Cell Host & Microbe
  • 03/10 The great escape? SARS-CoV-2 variants evading neutralizing responses: Cell Host & Microbe
  • 03/10 Long-Haul Post–COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrome: The Swedish Experience | JACC: Case Reports
  • 03/10 Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England | medRxiv
  • 03/10 Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial | medRxiv
  • 03/10 Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine | NEJM
  • 03/10 Children and young people remain at low risk of COVID-19 mortality - The Lancet Child & Adolescent Health
  • 03/10 Surveillance of SARS-CoV-2 in Zimbabwe shows dominance of variants of concern - The Lancet Microbe
  • 03/11 Transmission of SARS-CoV-2 from asymptomatic and presymptomatic individuals in healthcare settings despite medical masks and eye protection | Clinical Infectious Diseases | Oxford Academic
  • 03/11 What level of neutralising antibody protects from COVID-19? | medRxiv
  • 03/11 Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies | Nature
  • 03/12 Immunity to SARS-CoV-2 variants of concern | Science
  • 03/12 T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals | Science Translational Medicine
  • 03/12 Potent SARS-CoV-2 Neutralizing Antibodies Directed Against Spike N-Terminal Domain Target a Single Supersite: Cell Host & Microbe
  • 03/12 Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity: Cell
  • 03/12 Are vaccines safe in patients with Long COVID? A prospective observational study. | medRxiv
  • 03/12 Perfect as the enemy of good: tracing transmissions with low-sensitivity tests to mitigate SARS-CoV-2 outbreaks - The Lancet Microbe
  • 03/12 Could a good night's sleep improve COVID-19 vaccine efficacy? - The Lancet Respiratory Medicine
  • 03/13 Probable airborne transmission of SARS-CoV-2 in a poorly ventilated restaurant - ScienceDirect
  • 03/15 Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients | Surgery | JAMA | JAMA Network
  • 03/15 Association of Clinical, Biological, and Brain Magnetic Resonance Imaging Findings With Electroencephalographic Findings for Patients With COVID-19 | Neurology | JAMA Network Open | JAMA Network
  • 03/15 SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19 | Science Translational Medicine
  • 03/15 The first 12 months of COVID-19: a timeline of immunological insights | Nature Reviews Immunology - Nature
  • 03/15 Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7 | Nature
  • 03/15 Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7 | Nature
  • 03/15 Common pitfalls and recommendations for using machine learning to detect and prognosticate for COVID-19 using chest radiographs and CT scans | Nature Machine Intelligence
  • 03/16 Structural impact on SARS-CoV-2 spike protein by D614G substitution | Science
  • 03/16 SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms: Cell
  • 03/16 N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2: Cell
  • 03/16 Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein: Cell
  • 03/16 Spread of a Variant SARS-CoV-2 in Long-Term Care Facilities in England | NEJM
  • 03/16 Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant | NEJM
  • 03/16 Vaccinating the oldest against COVID-19 saves both the most lives and most years of life | PNAS
  • 03/16 SARS-CoV-2 infection and transmission in primary schools in England in June–December, 2020 (sKIDs): an active, prospective surveillance study - The Lancet Child & Adolescent Health
  • 03/16 Arthritis after SARS-CoV-2 infection - The Lancet Rheumatology
  • 03/17 SARS-CoV-2 Epidemiology on a Public University Campus in Washington State | medRxiv
  • 03/17 An integrated analysis of contact tracing and genomics to assess the efficacy of travel restrictions on SARS-CoV-2 introduction and transmission in England from June to September, 2020 | medRxiv
  • 03/17 Associations of the BNT162b2 COVID-19 vaccine effectiveness with patient age and comorbidities | medRxiv
  • 03/17 Factors associated with myocardial SARS-CoV-2 infection, myocarditis, and cardiac inflammation in patients with COVID-19 | Modern Pathology
  • 03/17 Shifting attention to accuracy can reduce misinformation online | Nature
  • 03/17 Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant | NEJM
  • 03/17 Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine | NEJM
  • 03/17 Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study - The Lancet
  • 03/18 Myocarditis in naturally infected pets with the British variant of COVID-19 | bioRxiv
  • 03/18 Association between living with children and outcomes from covid-19: OpenSAFELY cohort study of 12 million adults in England | The BMJ
  • 03/18 Antivirals with common targets against highly pathogenic viruses: Cell
  • 03/18 Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February - Eurosurveillance
  • 03/18 Early Release - Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 during Border Quarantine and Air Travel, New Zealand (Aotearoa) - Volume 27, Number 5—May 2021 - Emerging Infectious Diseases journal - CDC
  • 03/19 Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination | Infectious Diseases | JAMA | JAMA Network
  • 03/19 Combining initial chest CT with clinical variables in differentiating coronavirus disease 2019 (COVID-19) pneumonia from influenza pneumonia | Scientific Reports
  • 03/20 Infection and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant: Cell Host & Microbe
  • 03/20 SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies: Cell
  • 03/20 Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study - The Lancet
  • 03/22 Association of Age With SARS-CoV-2 Antibody Response | Adolescent Medicine | JAMA Network Open | JAMA Network
  • 03/22 COVID-19 Survivors’ Reports of the Timing, Duration, and Health Impacts of Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection | medRxiv
  • 03/23 Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation | eLife
  • 03/23 Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers” - Graham - - Annals of Clinical and Translational Neurology - Wiley Online Library
  • 03/23 The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia | Science
  • 03/23 Emergence of the E484K Mutation in SARS-CoV-2 Lineage B.1.1.220 in Upstate New York | medRxiv
  • 03/23 Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. | medRxiv
  • 03/23 SARS-CoV-2 Infection after Vaccination in Health Care Workers in California | NEJM
  • 03/23 BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers | NEJM
  • 03/23 Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine | NEJM
  • 03/23 Early Evidence of the Effect of SARS-CoV-2 Vaccine at One Medical Center | NEJM
  • 03/23 Higher airborne pollen concentrations correlated with increased SARS-CoV-2 infection rates, as evidenced from 31 countries across the globe | PNAS
  • 03/23 Using artificial intelligence to improve COVID-19 rapid diagnostic test result interpretation | PNAS
  • 03/23 Impacts of introducing and lifting nonpharmaceutical interventions on COVID-19 daily growth rate and compliance in the United States | PNAS
  • 03/23 Rapid identification and tracking of SARS-CoV-2 variants of concern - The Lancet
  • 03/23 Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study - The Lancet Microbe
  • 03/24 B.1.526 SARS-CoV-2 variants identified in New York City are neutralized by vaccine-elicited and therapeutic monoclonal antibodies | bioRxiv
  • 03/24 Quadrivalent influenza nanoparticle vaccines induce broad protection | Nature
  • 03/24 New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications | NEJM
  • 03/25 Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England | Nature
  • 03/25 SARS-CoV-2 infection of the oral cavity and saliva | Nature Medicine
  • 03/25 Performance and operational feasibility of antigen and antibody rapid diagnostic tests for COVID-19 in symptomatic and asymptomatic patients in Cameroon: a clinical, prospective, diagnostic accuracy study - The Lancet Infectious Diseases
  • 03/26 Case Study: Longitudinal immune profiling of a SARS-CoV-2 reinfection in a solid organ transplant recipient | medRxiv
  • 03/26 Dramatic drop of new SARS-CoV-2 infections among health care workers after the first dose of the BNT162b2 mRNA Covid-19 Vaccine | medRxiv
  • 03/26 First manifestation of adult-onset Still's disease after COVID-19 - The Lancet Rheumatology
  • 03/28 Emergence of a SARS-CoV-2 E484K variant of interest in Arizona | medRxiv
  • 03/29 SARS-CoV2 Nsp16 activation mechanism and a cryptic pocket with pan-coronavirus antiviral potential: Biophysical Journal
  • 03/29 Clinical performance evaluation of SARS-CoV-2 rapid antigen testing in point of care usage in comparison to RT-qPCR | medRxiv
  • 03/29 Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma | Nature
  • 03/29 The spatial landscape of lung pathology during COVID-19 progression | Nature
  • 03/29 Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine | Nature Medicine
  • 03/29 Early Release - Epidemiologic Evidence for Airborne Transmission of SARS-CoV-2 during Church Singing, Australia, 2020 - Volume 27, Number 6—June 2021 - Emerging Infectious Diseases journal - CDC
  • 03/30 Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States: Cell
  • 03/30 Antibody evasion by the P.1 strain of SARS-CoV-2: Cell
  • 03/30 mRNA vaccines take on immune tolerance | Nature Biotechnology
  • 03/30 Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial - The Lancet
  • 03/30 Pandemic moves and countermoves: vaccines and viral variants - The Lancet
  • 03/31 Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study | The BMJ
  • 03/31 Alterations in T and B cell function persist in convalescent COVID-19 patients: Med - Cell

    April 2021

  • 04/01 Computational epitope map of SARS-CoV-2 spike protein - PLOS
  • 04/01 Systems serology detects functionally distinct coronavirus antibody features in children and elderly | Nature Communications - Nature
  • 04/01 Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination | Nature Reviews Immunology
  • 04/01 Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2 | Nature Medicine
  • 04/01 Early Release - Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil - Volume 27, Number 5—May 2021 - Emerging Infectious Diseases journal - CDC
  • 04/02 X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease | Science
  • 04/02 Qualitatively distinct modes of Sputnik V vaccine-neutralization escape by SARS-CoV-2 Spike variants | medRxiv
  • 04/05 Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses: Immunity
  • 04/05 SARS-CoV-2 infectivity by viral load, S gene variants and demographic factors and the utility of lateral flow devices to prevent transmission | medRxiv
  • 04/06 Trends in Geographic and Temporal Distribution of US Children With Multisystem Inflammatory Syndrome During the COVID-19 Pandemic | Pediatrics | JAMA Pediatrics | JAMA Network
  • 04/06 Administration of a Second Dose of the Moderna COVID-19 Vaccine After an Immediate Hypersensitivity Reaction With the First Dose: Two Case Reports | Annals of Internal Medicine
  • 04/06 Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19 | Nature Reviews Immunology
  • 04/06 Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization | NEJM
  • 04/06 Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19 | NEJM
  • 04/06 Overdispersion in COVID-19 increases the effectiveness of limiting nonrepetitive contacts for transmission control | PNAS
  • 04/06 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records - The Lancet Psychiatry
  • 04/07 Reactive Infectious Mucocutaneous Eruption Associated With SARS-CoV-2 Infection | Dermatology | JAMA Dermatology | JAMA Network
  • 04/07 Effectiveness of CoronaVac in the setting of high SARS-CoV-2 P.1 variant transmission in Brazil: A test-negative case-control study | medRxiv
  • 04/07 Drugs that inhibit TMEM16 proteins block SARS-CoV-2 Spike-induced syncytia | Nature
  • 04/07 Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351 | NEJM
  • 04/07 Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351) | NEJM
  • 04/07 SARS-CoV-2 spike E484K mutation reduces antibody neutralisation - ScienceDirect
  • 04/07 Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study - The Lancet Microbe
  • 04/08 Early T cell and binding antibody responses are associated with Covid-19 RNA vaccine efficacy onset: Med
  • 04/09 Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals | medRxiv
  • 04/09 Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination | NEJM
  • 04/09 SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) - ScienceDirect
  • 04/09 Correlates of protection from SARS-CoV-2 infection - The Lancet
  • 04/09 Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial - The Lancet Respiratory Medicine
  • 04/12 Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity: Cell
  • 04/12 Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV | Nature
  • 04/12 Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study - The Lancet Infectious Diseases
  • 04/12 Lack of detail in population-level data impedes analysis of SARS-CoV-2 variants of concern and clinical outcomes - The Lancet Infectious Diseases
  • 04/12 Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study - The Lancet Public Health
  • 04/13 Ranking the risk of animal-to-human spillover for newly discovered viruses | PNAS
    | Main | News | Articles | Papers |